Maria Bach Laursen - Concepedia

Author

Maria Bach Laursen

Aarhus University ORCID

Also Known As

Laursen, Maria Bach, M. B. Laursen, Maria B Laursen, Maria B. Laursen, Maria Bach Laursen, Marie Brunsgaard Laursen

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Aarhus University Aalborg University Hospital Aalborg University University of Southern Denmark Aarhus University Hospital

About

Maria Bach Laursen is an author at Aarhus University specializing in medicine, genome editing, and non-coding rna.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	253
2	Natural Sciences	1	1	190
3	Immunology	1	1	63
4	Molecular Biology	1	1	190
5	Pathology	1	1	63

Maria Bach Laursen

Publications

Citations

H-Index

Page 1

	Year	Citations
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity Jesper B. Bramsen, Maria Bach Laursen, A. Nielsen, Nucleic Acids Research	2009	349
Improved silencing properties using small internally segmented interfering RNAs Jesper B. Bramsen, Maria Bach Laursen, Christian Kroun Damgaard, Nucleic Acids Research Rna InterferenceNatural SciencesSisirna DesignMolecular BiologyInterfering Rnas	2007	190
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance <i>in vitro</i> and <i>in vivo</i> Maria Bach Laursen, Malgorzata Maria Pakula, Shan Gao, Molecular BioSystems	2010	116
Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis Karen Dybkær, Martin Bøgsted, Steffen Falgreen, Journal of Clinical Oncology	2015	115
High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma Sara Correia Marques, Benyamin Ranjbar, Maria Bach Laursen, Experimental Hematology Lymphoid NeoplasiaOncologyMedicineImmunologyHigh Mir-34a Expression	2016	63
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models Steffen Falgreen, Karen Dybkær, Ken H. Young, BMC Cancer	2015	61
The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines Linn Reinholdt, Maria Bach Laursen, Alexander Schmitz, Biomarker Research	2016	31
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients Amanda Frydendahl, Christine Gaasdal Kassentoft, Michael Knudsen, BMC Cancer	2019	28
High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients Maria Bach Laursen, Linn Reinholdt, Anna A. Schönherz, Oncotarget	2019	27
Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition Steffen Falgreen, Maria Bach Laursen, Julie Støve Bødker, BMC Bioinformatics	2014	21

Page 1